OAC
GRNA

OMERS Administration Corp’s GreenLight Biosciences Holdings, PBC Common Stock GRNA Stock Holding History

OMERS Administration Corp’s Portfolio GRNA Stock Details GRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-78,937
Closed -$783K – 504
2021
Q4 		$783K Buy
+78,937
New +$785K 0.01% 118

Other funds holding GRNA

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
VS
VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return
CGC
Continental Grain Company New York $366M AUM 0.18% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
TCM
Tao Capital Management San Francisco, California $119M AUM 87.46% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OCMH
Oxbow Capital Management (HK) Hong Kong $371M AUM 383.45% 1-Year Est. Return

OMERS Administration Corp's GRNA Position: Q1 2022 in Review

OMERS Administration Corp sold out of GreenLight Biosciences Holdings, PBC Common Stock (GRNA) in Q1 2022, closing a stake of 78,937 shares — an estimated $783K sold.

OMERS Administration Corp first reported a position in GRNA in Q4 2021 and held it in 1 quarter. The position peaked at $783K in Q4 2021. 39 funds tracked by Wall St. Rank hold GRNA as of Q1 2022.

  • OMERS Administration Corp reported no remaining GreenLight Biosciences Holdings, PBC Common Stock position as of Q1 2022 after selling out during the quarter.
  • OMERS Administration Corp sold 78,937 GreenLight Biosciences Holdings, PBC Common Stock shares in Q1 2022, an estimated $783K.
  • OMERS Administration Corp first reported a position in GreenLight Biosciences Holdings, PBC Common Stock in Q4 2021 and held it in 1 quarter.
  • OMERS Administration Corp's GreenLight Biosciences Holdings, PBC Common Stock position peaked at $783K in Q4 2021.
  • 39 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Common Stock as of Q1 2022.

Based on OMERS Administration Corp's 13F filing for Q1 2022, filed 12 May 2022.